Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 9/2013

01-09-2013 | Letter to the Editor

Primary adrenal de novo CD5-positive diffuse large B cell lymphoma

Authors: Armin Rashidi, Catherine W. Bergeron, Stephen I. Fisher, Ian A. Chen

Published in: Annals of Hematology | Issue 9/2013

Login to get access

Excerpt

Dear Editor, …
Literature
1.
2.
Wang J, Sun NC, Renslo R, Chuang CC, Tabbarah HJ, Barajas L, French SW (1998) Clinically silent primary adrenal lymphoma: a case report and review of the literature. Am J Hematol 58:130–136PubMedCrossRef
3.
Wu HC, Shih LY, Chen TC, Chu SH, Tsai CC (1999) A patient with bilateral primary adrenal lymphoma, presenting with fever of unknown origin and achieving long-term disease-free survival after resection and chemotherapy. Ann Hematol 78:289–292PubMedCrossRef
4.
Ellis RD, Read D (2000) Bilateral adrenal non-Hodgkin’s lymphoma with adrenal insufficiency. Postgrad Med J 76:508–509PubMedCrossRef
5.
Taniguchi M, Oka K, Hiasa A, Yamaguchi M, Ohno T, Kita K, Shiku H (1998) De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood 91:1145–1151PubMed
6.
Yamaguchi M, Seto M, Okamoto M, Ichinohasama R, Nakamura N, Yoshino T, Suzumiya J, Murase T, Miura I, Akasaka T, Tamaru J, Suzuki R, Kagami Y, Hirano M, Morishima Y, Ueda R, Shiku H, Nakamura S (2002) De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood 99:815–821PubMedCrossRef
7.
Niitsu N, Okamoto M, Tamaru JI, Yoshino T, Nakamura N, Nakamura S, Ohshima K, Nakamine H, Hirano M (2010) Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma. Ann Oncol 21:2069–2074PubMedCrossRef
8.
Kaneko H, Shimura K, Horiike S, Kuroda J, Matsumoto Y, Yokota S, Nishida K, Ohkawara Y, Taniwaki M (2011) Cytogenetic analysis of de novo CD5-positive diffuse large B-cell lymphoma. Asia Pac J Clin Oncol 7:346–350PubMedCrossRef
9.
Kobayashi T, Yamaguchi M, Kim S, Morikawa J, Ogawa S, Ueno S, Suh E, Dougherty E, Shmulevich I, Shiku H, Zhang W (2003) Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5− diffuse large B-cell lymphomas. Cancer Res 63:60–66PubMed
10.
Yin Z, Giacomello E, Gabriele E, Zardi L, Aota S, Yamada KM, Skerlavaji B, Doliana R, Colombatti A, Perris R (1999) Cooperative activity of α4β1 and α4β7 integrins in mediating human B-cell lymphoma adhesion and chemotaxis on fibronectin through recognition of multiple synergizing binding sites within the central cell-binding domain. Blood 93:1221–1230PubMed
11.
Terol MJ, Lopez-Guillermo A, Bosch F, Villamor N, Cid MC, Campo E, Montserrat E (1999) Expression of β-integrin adhesion molecule in non-Hodgkin’s lymphoma: correlation with clinical and evolutive features. J Clin Oncol 17:1869–1875PubMed
Metadata
Title
Primary adrenal de novo CD5-positive diffuse large B cell lymphoma
Authors
Armin Rashidi
Catherine W. Bergeron
Stephen I. Fisher
Ian A. Chen
Publication date
01-09-2013
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 9/2013
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-013-1690-8

Other articles of this Issue 9/2013

Annals of Hematology 9/2013 Go to the issue

Original Article

Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide–dexamethasone incorporated into double autologous transplantation

Letter to the Editor

A “complicated” fracture: a Philadelphia chromosome-positive myeloid sarcoma of the bone

Letter to the Editor

Immune aregenerative anemia without erythroblastopenia: a previously undescribed condition

Letter to the Editor

Sustained complete remission in an elderly patient with a blastic plasmacytoid dendritic cell neoplasm following autologous peripheral blood stem cell transplantation

Letter to the Editor

Retroperitoneal follicular lymphoma presenting with gastric varices and splenic artery pseudoaneurysm

Letter to the Editor

Daytime pulse oximetry measurements may not predict nocturnal desaturations in adult sickle cell patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits